Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

A chatbot designed to educate cancer patients on genetic testing and help them access tests appears to be effective, according to research presented at the 50th Annual ONS Congress.

A screening program enabled timely screenings for cardiotoxicity and allowed patients to receive optimal cancer treatment.

The decision to choose systemic adjuvant therapy warrants careful discussion on its benefits and risks,” researchers wrote.

Five-year data from the KEYNOTE-048 trial support the use of pembrolizumab and pembrolizumab-chemotherapy as standards of care, researchers wrote.

(HealthDay News) — The US Food and Drug Administration (FDA) announced that it is shifting away from requiring animal testing for the development of monoclonal antibodies and other drugs and will ...

The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

Data suggest that taletrectinib “provides clinically meaningful tumor shrinkage and prolonged disease control as a treatment option for advanced ROS1+ NSCLC, regardless of treatment history,” ...

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

The Honoring Our Fallen Heroes Act is considered crucial by its supporters, with climate change fueling an increase in wildfire frequency and firefighting deemed carcinogenic by the World Health ...

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They e ...